Literature DB >> 17098136

Usefulness of clinical, electrocardiographic, and echocardiographic parameters to detect cardiac asynchrony in patients with left ventricular dysfunction secondary to ischemic or nonischemic heart disease.

Leopoldo Perez de Isla1, Pilar Ortiz Oficialdegui, Jose Florit, Miguel Angel Garcia-Fernandez, Violeta Sanchez, José Zamorano.   

Abstract

OBJECTIVES: Specific evaluation using echocardiographic Doppler is superior to the measurement of the QRS complex to detect cardiac asynchrony. Nevertheless, no clinical, electrocardiographic, or echocardiographic parameters have been evaluated to obtain an accurate and easy-to-use marker of cardiac asynchrony in patients with depressed left ventricular (LV) ejection fraction. Our aim was to determine whether there is any marker of cardiac asynchrony in patients with LV systolic dysfunction that allows us to obviate the performance of a specific echocardiographic study before cardiac resynchronization therapy.
METHODS: In all, 316 consecutive patients with LV ejection fraction less than 40% were enrolled. Interventricular asynchrony was defined as an interventricular mechanical delay longer than 40 milliseconds. Intraventricular asynchrony was defined as the difference between time from Q wave to LV ejection end and the time from Q wave to the end of the systolic wave of the most delayed basal segment by Doppler tissue imaging greater than 50 milliseconds.
RESULTS: In all, 177 (56%) had ischemic and 139 (44%) had nonischemic heart disease. The logistic regression analysis showed that only the presence of left bundle branch block was an independent predictor of interventricular asynchrony despite the cause of the underlying disease (odds ratio and 95% confidence interval 7.2 [3.9-13.4], P < .001; 5.99 [2.7-13.2], P < .001; and 8.75 [3.2-23.8], P < .001 for the total population, ischemic and nonischemic groups, respectively). Nevertheless, none of the studied parameters was found as a predictor of intraventricular asynchrony.
CONCLUSIONS: The presence of left bundle branch block is a marker of interventricular asynchrony in patients with ventricular dysfunction despite the cause of the underlying cardiac disease. Nevertheless, intraventricular cardiac asynchrony cannot be detected using conventional parameters. A specific echocardiographic evaluation before cardiac resynchronization therapy must be performed in all these patients. Our aim was to determine whether there is any marker of cardiac asynchrony in patients with left ventricular systolic dysfunction that allows us to obviate the performance of a specific echocardiographic study before cardiac resynchronization therapy. Our results showed that only the presence of left bundle branch block was an independent predictor of interventricular asynchrony despite the cause of the underlying disease but none of the studied parameters was found as a predictor of intraventricular asynchrony.

Entities:  

Mesh:

Year:  2006        PMID: 17098136     DOI: 10.1016/j.echo.2006.05.015

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  3 in total

1.  An algorithm for extracting intracranial pressure latency relative to electrocardiogram R wave.

Authors:  Xiao Hu; Peng Xu; Darrin J Lee; Paul Vespa; Kevin Baldwin; Marvin Bergsneider
Journal:  Physiol Meas       Date:  2008-03-17       Impact factor: 2.833

2.  A new baseline scoring system may help to predict response to cardiac resynchronization therapy.

Authors:  Xuedong Shen; Chandra K Nair; Wilbert S Aronow; Mak J Holmberg; Madhu Reddy; Kishley Anand; Tom Hee; Aimin Chen; Xiang Fang; Stephanie Maciejewski; Dennis J Esterbrooks
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

3.  Evaluation of left ventricular dyssynchrony using combined pulsed wave and tissue Doppler imaging.

Authors:  Xuedong Shen; Wilbert S Aronow; Kishlay Anand; Chandra K Nair; Mark J Holmberg; Tom Hee; Stephanie Maciejewski; Dennis J Esterbrooks
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.